urmjУральский медицинский журналUral Medical Journal2949-4389Ural State Medical University10.25694/URMJ.2018.09.28urmj-296Research ArticleОНКОУРОЛОГИЯСравнительные канцерспецифические результаты радикальной цистэктомии при раке мочевого пузыря стадий рїЗ и рї4а. ретроспективное исследование в одиночном центреComparative cancer-specific results of radical cystectomy in bladder cancer of stages pT3 and pT4a. Retrospective study in a single centerВасильевО. Н.VasilyevO. N.vasilyev_ on@mail.ruКоганМ. И.KoganM. I.noemail@neicon.ruПерепечайВ. А.PerepechayV. A.noemail@neicon.ruИванниковВ. В.IvannikovV. V.noemail@neicon.ruГБОУ ВПО Ростовского государственного медицинского университетаRussian Federation201814042021099094Copyright © Васильев О.Н., Коган М.И., Перепечай В.А., Иванников В.В., 20212021Васильев О.Н., Коган М.И., Перепечай В.А., Иванников В.В.Vasilyev O.N., Kogan M.I., Perepechay V.A., Ivannikov V.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.umjusmu.ru/jour/article/view/296ReferencesЧиссов, В.И. Злокачественные новообразования в России в 2011 году (заболеваемость и смертность) / под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой - М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России, 2013. - ил. - 289 с.Чиссов, В.И. Злокачественные новообразования в России в 2011 году (заболеваемость и смертность) / под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой - М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России, 2013. - ил. - 289 с.рТЗ Substaging is a Prognostic Indicator for LymphNode Negative Urotheli al. Carcinoma of the Bladder/D.Tilki, R.S. Svatek, et al//JUrology- 2010. -Vol. 184, Issue 2, Pages470-474.рТЗ Substaging is a Prognostic Indicator for LymphNode Negative Urotheli al. Carcinoma of the Bladder/D.Tilki, R.S. Svatek, et al//JUrology- 2010. -Vol. 184, Issue 2, Pages470-474.Cystectomy for bladder cancer: a contemporary series/ G. Dalbagni, E. Genega, et al.//J Urol. -2001;165:1111.Cystectomy for bladder cancer: a contemporary series/ G. Dalbagni, E. Genega, et al.//J Urol. -2001;165:1111.Cystectomyfor transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era/R. Hautmann, J. Gschwend, et al. //J Urol.-2006;176:486.Cystectomyfor transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era/R. Hautmann, J. Gschwend, et al. //J Urol.-2006;176:486.Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy/ S. Madersbacher, W. Hochreiter, et al.7/J Clin 0ncol.-2003;21:690._Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy/ S. Madersbacher, W. Hochreiter, et al.7/J Clin 0ncol.-2003;21:690._Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium / S. Shariat, P. Karakiewicz, G. Palapattu, et al.//J Urol. -2006;176:2414.Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium / S. Shariat, P. Karakiewicz, G. Palapattu, et al.//J Urol. -2006;176:2414.Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy / S. Shariat, G. Palapattu, P. Karakiewicz, et al. /Eur Urol.-2007;51:137.Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy / S. Shariat, G. Palapattu, P. Karakiewicz, et al. /Eur Urol.-2007;51:137.Microscopic and gross extravesical extension in pathological staging ofbladder cancer /М. Quek, J. Stein, P. Clark, et al//J Urol. - 2004;171:640.Microscopic and gross extravesical extension in pathological staging ofbladder cancer /М. Quek, J. Stein, P. Clark, et al//J Urol. - 2004;171:640.Cystectomy for bladder cancer: a contemporary series / G. Dalbagni, E. Genega, M. Hashibe, et al. // J Urol. -2001; 165:1111.Cystectomy for bladder cancer: a contemporary series / G. Dalbagni, E. Genega, M. Hashibe, et al. // J Urol. -2001; 165:1111.Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes /KJ Boudreaux, SS Chang, WT Lowrance, et al. // Cancer. - 2009; 115:770.Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes /KJ Boudreaux, SS Chang, WT Lowrance, et al. // Cancer. - 2009; 115:770.Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival / PJ Bastian, GC Hutterer, SF Shariat, et al.//BJU Int. - 2008;101:450.Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival / PJ Bastian, GC Hutterer, SF Shariat, et al.//BJU Int. - 2008;101:450.Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy / Y Lotan, A Gupta, SF Shariat, et al. Hi Clin Oncol. -2005;23:6533.Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy / Y Lotan, A Gupta, SF Shariat, et al. Hi Clin Oncol. -2005;23:6533.Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy /ML Quek, JP Stein, PW Nichols, etal. //J Urol.-2005; 174:103.Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy /ML Quek, JP Stein, PW Nichols, etal. //J Urol.-2005; 174:103.Clinical outcome of radical cystectomy for patients with pT4 bladder cancer/J Furukawa, H Miyake, I Hara, etal.// Int J Urol.-2008; 15:58.Clinical outcome of radical cystectomy for patients with pT4 bladder cancer/J Furukawa, H Miyake, I Hara, etal.// Int J Urol.-2008; 15:58.
The authors declare that there are no conflicts of interest present.